Where is ImmunOs headquartered?

ImmunOs is located in Schlieren, zurich.

Who invested in ImmunOs?

ImmunOs has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for ImmunOs?

ImmunOs closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

immunostherapeutics.com

ImmunOs

Immunos is a Switzerland-based biotechnology company that develops and commercializes therapeutics for the treatment of cancer and autoimmune diseases.

Business Model:

Revenue: $4M

Employees: 11-50

Geographic Data

Address: Wagistrasse 14

City: Schlieren

State: zurich

Zip: 8952

Country: CH

Financial Info

Stage:

series b

Raised Last:

$73M

Raised Total:

$90M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Immunos is a Switzerland-based biotechnology company that develops and commercializes therapeutics for the treatment of cancer and autoimmune diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2018	Venture Round		-	Schroder Adveq UZH Life Sciences Fund Schroder Adveq UZH Life Sciences Fund
6/2022	Series B		$0	BioMedPartners Fiscus Financial Gimv GL Capital Lightspeed Venture Partners Mission BioCapital PEAK6 Investments LLC Pfizer Venture Investments Samsara BioCapital Schroder Adveq BioMedPartners Fiscus Financial Gimv GL Capital Lightspeed Venture Partners Mission BioCapital PEAK6 Investments LLC Pfizer Venture Investments Samsara BioCapital Schroder Adveq
12/2017	Seed Round		$2.3M
12/2019	Series A		$15.2M	BioMedPartners Redalpine Schroder Adveq Wille Finance AG
6/2022	Series B		$74M	Samsara BioCapital Lightspeed Venture Partners Gimv Mission BioCapital GL Capital PEAK6 Strategic Capital Fiscus Financial BioMed Partners Schroder Adveq
12/2019	Series A		$0	Bernina BioInvest BioMedPartners Daniel Vasella Pfizer Venture Investments Redalpine Reinhard Ambros Schroder Adveq Wille Finance Bernina BioInvest BioMedPartners Daniel Vasella Pfizer Venture Investments Redalpine Reinhard Ambros Schroder Adveq Wille Finance
12/2017	Unattributed		$2.3M
4/2021	Grant	2	-	European Union InnoSuisse European Union InnoSuisse
6/2022	Series B	10	$72.9M	BioMedPartners Fiscus Financial Gimv GL Capital Lightspeed Venture Partners Mission BioCapital PEAK6 Investments LLC Pfizer Venture Investments Samsara BioCapital Schroder Adveq BioMedPartners Fiscus Financial Gimv GL Capital Lightspeed Venture Partners Mission BioCapital PEAK6 Investments LLC Pfizer Venture Investments Samsara BioCapital Schroder Adveq
4/2021	Grant	2	-	European Union InnoSuisse European Union InnoSuisse
12/2019	Series A	8	$15.2M	Bernina BioInvest BioMedPartners Daniel Vasella Pfizer Venture Investments Redalpine Reinhard Ambros Schroder Adveq Wille Finance Bernina BioInvest BioMedPartners Daniel Vasella Pfizer Venture Investments Redalpine Reinhard Ambros Schroder Adveq Wille Finance
10/2018	Venture Round	2	-	Schroder Adveq UZH Life Sciences Fund Schroder Adveq UZH Life Sciences Fund

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details